Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - aspirin - dispersible tablet - 300mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cefaclor monohydrate -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - cefaclor monohydrate -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

spg pharma (malaysia) sdn bhd - loperamide hydrochloride -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - doxazosin mesylate -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - cefaclor monohydrate -

USA - engelsk - NLM (National Library of Medicine)

antigen laboratories, inc. - pea (unii: w4x7h8gyfm) (pea - unii:w4x7h8gyfm) - pea 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

milrin pharmaceutical co. (m) sdn bhd - cimetidine -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

milrin pharmaceutical co. (m) sdn bhd - cimetidine -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ezz life science holdings limited - ganoderma lucidum, quantity: 50 mg (equivalent: ganoderma lucidum, qty 1 g); nicotinic acid, quantity: 50 mg; vitex agnus-castus, quantity: 100 mg (equivalent: vitex agnus-castus, qty 500 mg); evening primrose oil, quantity: 24 mg; vaccinium macrocarpon, quantity: 160 mg (equivalent: vaccinium macrocarpon, qty 8 g); zinc oxide, quantity: 7.472 mg (equivalent: zinc, qty 6 mg); taurine, quantity: 50 mg - tablet, film coated - excipient ingredients: maltodextrin; tapioca starch; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; croscarmellose sodium; povidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; carmine - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support immune system health ; traditionally used in western herbal medicine to decrease/reduce/relieve menstrual cycle irregularity/irregular periods ; traditionally used in western herbal medicine to maintain/support/regulate healthy menstrual cycle ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of premenstrual tension ; traditionally used in western herbal medicine to maintain/support urinary tract health